These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24675794)

  • 1. Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform.
    Fischer NO; Weilhammer DR; Dunkle A; Thomas C; Hwang M; Corzett M; Lychak C; Mayer W; Urbin S; Collette N; Chiun Chang J; Loots GG; Rasley A; Blanchette CD
    PLoS One; 2014; 9(3):e93342. PubMed ID: 24675794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different apolipoproteins impact nanolipoprotein particle formation.
    Chromy BA; Arroyo E; Blanchette CD; Bench G; Benner H; Cappuccio JA; Coleman MA; Henderson PT; Hinz AK; Kuhn EA; Pesavento JB; Segelke BW; Sulchek TA; Tarasow T; Walsworth VL; Hoeprich PD
    J Am Chem Soc; 2007 Nov; 129(46):14348-54. PubMed ID: 17963384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalized delivery of adjuvant and antigen using nanolipoprotein particles enhances the immune response to recombinant antigens.
    Fischer NO; Rasley A; Corzett M; Hwang MH; Hoeprich PD; Blanchette CD
    J Am Chem Soc; 2013 Feb; 135(6):2044-7. PubMed ID: 23331082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanolipoprotein Particles as a Delivery Platform for Fab Based Therapeutics.
    Darwish M; Shatz W; Leonard B; Loyet K; Barrett K; Wong JL; Li H; Abraham R; Lin M; Franke Y; Tam C; Mortara K; Zilberleyb I; Blanchette C
    Bioconjug Chem; 2020 Aug; 31(8):1995-2007. PubMed ID: 32701261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles.
    Blanchette CD; Segelke BW; Fischer N; Corzett MH; Kuhn EA; Cappuccio JA; Benner WH; Coleman MA; Chromy BA; Bench G; Hoeprich PD; Sulchek TA
    Int J Mol Sci; 2009 Jul; 10(7):2958-2971. PubMed ID: 19742178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanolipoprotein particles for co-delivery of cystine-knot peptides and Fab-based therapeutics.
    Darwish M; Gao X; Shatz W; Li H; Lin M; Franke Y; Tam C; Mortara K; Zilberleyb I; Hannoush RN; Blanchette C
    Nanoscale Adv; 2021 Jun; 3(13):3929-3941. PubMed ID: 36133017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Cross-Linking of Nanolipoprotein Particles Substantially Enhances Serum Stability and Cellular Uptake.
    Gilmore SF; Blanchette CD; Scharadin TM; Hura GL; Rasley A; Corzett M; Pan CX; Fischer NO; Henderson PT
    ACS Appl Mater Interfaces; 2016 Aug; 8(32):20549-57. PubMed ID: 27411034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA.
    He W; Evans AC; Rasley A; Bourguet F; Peters S; Kamrud KI; Wang N; Hubby B; Felderman M; Gouvis H; Coleman MA; Fischer NO
    Nanomedicine; 2020 Feb; 24():102154. PubMed ID: 31982617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of lipid mixing between bicelles and nanolipoprotein particles.
    Lai G; Forti KM; Renthal R
    Biophys Chem; 2015 Feb; 197():47-52. PubMed ID: 25660392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid composition dictates serum stability of reconstituted high-density lipoproteins: implications for in vivo applications.
    Gilmore SF; Carpenter TS; Ingólfsson HI; Peters SKG; Henderson PT; Blanchette CD; Fischer NO
    Nanoscale; 2018 Apr; 10(16):7420-7430. PubMed ID: 29564446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of
    Weilhammer DR; Dunkle AD; Boone T; Gilmore SF; Khemmani M; Peters SKG; Hoeprich PD; Fischer NO; Blanchette CD; Driks A; Rasley A
    Front Immunol; 2020; 11():1264. PubMed ID: 32714323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations.
    Blanchette CD; Law R; Benner WH; Pesavento JB; Cappuccio JA; Walsworth V; Kuhn EA; Corzett M; Chromy BA; Segelke BW; Coleman MA; Bench G; Hoeprich PD; Sulchek TA
    J Lipid Res; 2008 Jul; 49(7):1420-30. PubMed ID: 18403317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using ApoE Nanolipoprotein Particles To Analyze SNARE-Induced Fusion Pores.
    Bello OD; Auclair SM; Rothman JE; Krishnakumar SS
    Langmuir; 2016 Mar; 32(12):3015-23. PubMed ID: 26972604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-III.
    Fischer NO; Blanchette CD; Segelke BW; Corzett M; Chromy BA; Kuhn EA; Bench G; Hoeprich PD
    PLoS One; 2010 Jul; 5(7):e11643. PubMed ID: 20657844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
    Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
    J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111 labeling of high-density lipoprotein-mimicking phospholipid-styrene maleic acid copolymer complexes and its biodistribution in mice.
    Tanaka M; Hosotani A; Mukai T
    J Labelled Comp Radiopharm; 2018 Sep; 61(11):857-863. PubMed ID: 29972867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immobilization of His-tagged proteins on nickel-chelating nanolipoprotein particles.
    Fischer NO; Blanchette CD; Chromy BA; Kuhn EA; Segelke BW; Corzett M; Bench G; Mason PW; Hoeprich PD
    Bioconjug Chem; 2009 Mar; 20(3):460-5. PubMed ID: 19239247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antigen-specific CD4
    Weilhammer D; Dunkle AD; Blanchette CD; Fischer NO; Corzett M; Lehmann D; Boone T; Hoeprich P; Driks A; Rasley A
    Vaccine; 2017 Mar; 35(11):1475-1481. PubMed ID: 28214044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
    Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
    Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge.
    Weilhammer DR; Blanchette CD; Fischer NO; Alam S; Loots GG; Corzett M; Thomas C; Lychak C; Dunkle AD; Ruitenberg JJ; Ghanekar SA; Sant AJ; Rasley A
    Biomaterials; 2013 Dec; 34(38):10305-18. PubMed ID: 24075406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.